Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAME Study
PACTR202001624880753Phase 4Recruiting
- Sponsor
- Naseer Ally
- Start
- Nov 2017
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4 trial of bevacizumab in diabetic macular edema (DME) (2 arms), sponsored by Naseer Ally. Started Nov 2017; status: recruiting.
02
Drugs
bevacizumab
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on PACTR202001624880753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202001624880753.